Home > No specific risk factors for clots with AstraZeneca says EMA chief

News
No specific risk factors for clots with AstraZeneca says EMA chief

Description

EMA Executive Director Emer Cooke says no specific risk factors are associated with clotting disorders resulting from the AstraZeneca coronavirus vaccine. SOUNDBITE

Added on the 07/04/2021 16:42:02 - Copyright : AFPTV - First images

To customise your video :

Or Create an account

More videos on the subject

  • Immune response 'plausible' explanation for AstraZeneca clots says EMA chief

    EMA Executive Director Emer Cooke says an immune response is a 'plausible' explanation for blood clots resulting from the AstraZeneca coronavirus vaccine. SOUNDBITE

    07/04/2021 - AFPTV - First images
  • Middle East tensions pose inflation risk: ECB chief

    Tensions in the Middle East and shipping disruptions in the Red Sea could push eurozone inflation higher again, European Central Bank president Christine Lagarde warns at a press conference in Frankfurt. SOUNDBITE

    25/01/2024 - AFPTV - First images
  • SVB collapse not 'significant risk' to Europe: EU economy chief

    The EU's economy commissioner says the collapse of Silicon Valley Bank in the United States does not pose a serious threat to Europe, amid investors' fears of contagion throughout the financial sector. "The possibility of indirect impact is something that we have to monitor but, at the moment, we don't see it as a significant risk," Paolo Gentiloni told reporters in Brussels as European stock were down heavily in afternoon trading. SOUNDBITE

    13/03/2023 - AFPTV - First images
  • IMF chief urges action to ward off global recession risk

    IMF chief Kristalina Georgieva warns the global recession risks are rising and urges policy action "to regroup and to rethink how can we adopt a more proactive precautionary mindset that we had in the past." SOUNDBITE

    06/10/2022 - AFPTV - First images
  • AstraZeneca vaccine benefits increase with age: EMA

    The deputy executive director of EU's drug watchdog says during a press conference that a review of AstraZeneca's Covid-19 vaccine found its benefits increase with age, despite links to blood clots. SOUNDBITE

    23/04/2021 - AFPTV - First images

More videosNews

Watch video of  - DemainEntreprendre - épisode 12 - Label : Economie wallonne -
News

DemainEntreprendre - épisode 12

29/04/2021 12:55:32